| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |